“Profit margins were impacted by higher raw material prices across all businesses and the weak performance of swine in animal protein other (APO)-Vietnam,” the company says in a results filing.
Amid a high-cost environment, Japfa has reported PATMI of US$46.3 million ($65.54 million) for 9MFY2022, down 59.3% from the same period last year.
Revenue, however, grew 10.5% to US$3.73 billion. This is driven by sales volume growth across all segments.
